Pro/Con debate: Is procalcitonin useful for guiding antibiotic decision making in critically ill patients?

Yahya Shehabi, Ian Seppelt

Research output: Contribution to journalReview ArticleResearchpeer-review

46 Citations (Scopus)

Abstract

You are concerned about the escalating use of antibiotics in your intensive care unit (ICU). This has put a strain on the ICU budget and is possibly resulting in the emergence of resistant bacteria. You review the situation with your team and one suggestion is to consider using biomarkers such as procalcitonin to better guide appropriate antibiotic decision making.

Original languageEnglish
Article number211
JournalCritical Care
Volume12
Issue number3
DOIs
Publication statusPublished - 2 May 2008
Externally publishedYes

Cite this